MKS (NASDAQ:MKSI – Get Free Report) had its target price lowered by stock analysts at Mizuho from $360.00 to $330.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the scientific and technical instruments company’s stock. Mizuho’s price target suggests a potential upside of 22.65% from the company’s previous close.
Other research analysts have also issued research reports about the company. Needham & Company LLC increased their price target on MKS from $360.00 to $390.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Wells Fargo & Company upped their target price on MKS from $300.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Friday, August 7th. TD Cowen reiterated a “buy” rating on shares of MKS in a report on Thursday, May 7th. Bank of America lifted their price target on shares of MKS from $380.00 to $500.00 and gave the company a “buy” rating in a research report on Tuesday, June 23rd. Finally, JPMorgan Chase & Co. boosted their price target on shares of MKS from $365.00 to $380.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $382.86.
Read Our Latest Research Report on MKS
MKS Price Performance
MKS (NASDAQ:MKSI – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.39. The company had revenue of $1.25 billion for the quarter, compared to analysts’ expectations of $1.20 billion. MKS had a net margin of 10.15% and a return on equity of 24.72%. The business’s revenue was up 28.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.77 EPS. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS. Equities research analysts anticipate that MKS will post 12.96 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, CEO John Tseng-Chung Lee sold 10,000 shares of the stock in a transaction on Friday, August 14th. The stock was sold at an average price of $302.01, for a total value of $3,020,100.00. Following the completion of the sale, the chief executive officer directly owned 134,776 shares of the company’s stock, valued at approximately $40,703,699.76. This represents a 6.91% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gerald G. Colella sold 20,000 shares of the firm’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $333.40, for a total value of $6,668,000.00. Following the transaction, the director owned 20,017 shares in the company, valued at approximately $6,673,667.80. This trade represents a 49.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 34,991 shares of company stock valued at $11,275,822. 0.57% of the stock is currently owned by company insiders.
Institutional Trading of MKS
Institutional investors and hedge funds have recently made changes to their positions in the company. Keating Financial Advisory Services Inc. bought a new position in shares of MKS during the second quarter valued at about $25,000. Global Retirement Partners LLC grew its position in MKS by 560.0% in the 4th quarter. Global Retirement Partners LLC now owns 165 shares of the scientific and technical instruments company’s stock worth $26,000 after purchasing an additional 140 shares in the last quarter. IFP Advisors Inc increased its stake in MKS by 616.7% in the 4th quarter. IFP Advisors Inc now owns 172 shares of the scientific and technical instruments company’s stock valued at $27,000 after buying an additional 148 shares during the last quarter. Allied Private Wealth LLC bought a new position in shares of MKS during the 2nd quarter worth approximately $33,000. Finally, Clearstead Trust LLC bought a new position in shares of MKS during the 2nd quarter worth approximately $36,000. Hedge funds and other institutional investors own 99.79% of the company’s stock.
MKS Company Profile
MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.
The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.
See Also
- Five stocks we like better than MKS
- 3 Contrarian Trades for a Market That Looks Too Hot
- The Bull Case for D-Wave After a Disappointing Earnings Season
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
Receive News & Ratings for MKS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS and related companies with MarketBeat.com's FREE daily email newsletter.
